A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi's sarcoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 90, Issue 5, 2000, Pages 612-617

  Gorsky, Meir ^a   Epstein, Joel B ^b,c,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANADA; CAUSE OF DEATH; HUMAN; JAW TUMOR; KAPOSI SARCOMA; MALE; MIDDLE AGED; MORTALITY; MOUTH TUMOR; REGISTER; SURVIVAL RATE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BRITISH COLUMBIA; CAUSE OF DEATH; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PALATAL NEOPLASMS; REGISTRIES; SARCOMA, KAPOSI; SURVIVAL RATE;

EID: 0034321868     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2000.109518     Document Type: Article

References (65)

1. Storm HH. Cancers of the soft tissues. Cancer Surv 1994;19-20,197-217.
2. MacKie RM. Tumors of the dermis. In: Mackie RM, editor. Skin Cancer 2nd ed. St Louis: Mosby; 1996. p. 303-6.
3. Epstein JB, Silverman S Jr. Head and neck malignancies associated with HIV infection. Oral Surg Oral Med Oral Pathol 1992;73:193-200.
4. Volberding PA. Kaposi's sarcoma and the acquired immunodeficiency syndrome. Med Clin North Am 1986;70:665-75.
5. Klein E, Schwartz RA. Cancer and the skin. In: Holland JF, Frei E, editors. Cancer medicine. 2nd ed. Philadelphia: Lea & Febiger; 1992. p. 2057-108.
6. Beral V, Peterman T, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-8.
7. Penn I. The occurrence of malignant tumors in immunosuppressed stages. Prog Allergy 1986;37:259-62.
8. Ficarra G, Berson AM, Silverman S Jr, Quivey JM, Lozada-nur F, Sooy DD, et al. Kaposi's sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects and treatment. Oral Surg Oral Med Oral Pathol 1988;66:543-50.
9. Silverman S Jr, Migliorati CA, Lozada-Nur F, Greenspan D, Conant MA. Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males. J Am Dent Assoc 1986;112:187-92.
10. Epstein JB, Lozada-Nur F, McLeod WA, Spinelli J. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome: review of management and report of the efficacy of intralesional vinblastine. Cancer 1989;64:2424-30.
11. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-9.
12. Dezube BJ. Clinical presentation and natural history of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin North Am 1996;10:1023-9.
13. McCormick SU. Intralesional vinblastine for the treatment of oral Kaposi's sarcoma: a report of 10 patients with 2-year follow-up. J Oral Maxillofac Surg 1996;54:583-7.
14. Gorsky M, Epstein JB. Head and neck and intra-oral soft tissue sarcomas. Oral Oncol. 1998;34: 292-b.
15. Jindal JR, Campbell BH, Ward TO, Almagro US. Kaposi's sarcoma of the oral cavity in a non-AIDS patient: case report and review of the literature. Head Neck 1995;17:64-8.
16. Groopman JE, Broder S. Cancer in AIDS and other immunodeficiency states. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 3rd ed. Philadelphia: JB Lippincott; 1989. p. 1959.
17. Reichart PA, Schiodt M. Non-pigmented oral Kaposi's sarcoma (AIDS). J Oral Maxillofac Surg 1989;18:197-9.
18. Cooper JS, Fried PR, Laubenstein LJ. Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma. JAMA 1984;252:934-5.
19. Epstein JB, Silverman S Jr, Gorsky M. The continuing epidemic of HIV and AIDS in 1998. J Can Dent Assoc 1998;64:426-30.
20. Hermans P. Epidemiology, etiology and pathogenesis, clinical presentations and therapeutic approaches in Kaposi's sarcoma: 15 year lessons from AIDS. Biomed Pharmacother 1998;52:440-6.
21. Aguirre JM, Echebarria MA, Ocina E, Rocaboda L, Montejo M. Reduction in HIV-associated oral lesions after highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:114-5.
22. Dios PD, Hermida AO, Alvarez CM, Garcia EV, Vasquea CM. Regression of AIDS-related Kaposi's sarcoma following ritonavir therapy. Oral Oncol 1998;34:236-8.
23. Krown SE. AIDS-associated Kaposi's sarcoma: pathogenesis, clinical course and treatment. AIDS 1988;2:71-80.
24. Brooks LA, Wilson AJ, Crook T. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 - a new human tumour virus. J Pathol 1997;182:262-5.
25. Kennedy MM, Lucas SB, Jones RR, Howells DD, Picton SJ, Hanks EE, et al. HHV-8 and Kaposi's sarcoma: a time cohort study. Molecul Pathol 1997;50:96-100.
26. Di Alberti L, Porter SR, Speight PM, Scully CM, Zakrzewsak JM, Williams IG, et al. Detection of human herpesvirus-8 DNA in oral ulcer tissues of HIV-infected individuals. Oral Dis 1997;3:133-4.
27. Webster-Cyriaque J, Edwards RH, Quinlivan EB, Patton L, Wohl D, Raab-Traub N. Epstein-Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions. J Infect Dis 1997;175:1324-32.
28. Flaitz CM, Jin YT, Hicks MJ, Nichols CM, Wang YW, Su IJ. Kaposi's sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma: a PCR and clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:259-64.
29. Hicks J, Flaitz C, Nichols M. AIDS-Kaposi's sarcoma and human herpes virus-8: detection by ultrastructural and RT-PCR means [abstract]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:209.
30. Koelle DM, Huang ML, Chandran B, Vieira J, Piepkorn M, Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 1997;176:94-102.
31. Di Alberti L, Ngui SL, Porter SR, Speight PM, Scully CM, et al. Presence of herpesvirus 8 variants in the oral tissues of human immunodeficiency virus-infected persons. J Infect Dis 1997;175:703-7.
32. Enwonwu CO. Pathogenesis of oral Kaposi's sarcoma in HIV-infection: relevance of endogenous glucocorticoid excess in blood and saliva. Eur J Cancer B Oral Oncol 1996;32B:271-4.
33. Safai B, Johnson KG, Myskowski PL, Koziner B, Yang SY, Cunningham-Rundles S, et al. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:744-50.
34. Epstein JB, Sherlock CH, Wolber RA. Oral manifestations of cytomegalovirus infection. Oral Surg Oral Med Oral Pathol 1993;75:443-51.
35. d'Arminio Monforte A, Vago L, Lazzarin A, Boldorini R, Bini T, Guzzetti S, et al. AIDS-defining disease in 250 HIV-infected patients: a comparative study of clinical and autopsy diagnoses. AIDS 1992;6:1159-64.
36. Hjalgrim H, Tulinius H, Dalberg J, Hardarson S, Frisch M, Melbye M. High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands. Brit J Cancer 1998;77:1190-3.
37. Epstein JB, Scully CS. HIV infection: clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol 1991;71:38-41.
38. Ficarra G, Eversole LE. HIV-related tumors of the oral cavity. Crit Rev Oral Biol Med 1994;5:159-85.
39. Nisce LZ, Safai B. Radiation therapy of Kaposi's sarcoma in AIDS: Memorial Sloan-Kettering experience. Front Radiat Ther Oncol 1985;19:133-7.
40. Berson AM, Quivey JM, Harris JW, Wara WM. Radiation therapy for AIDS-related Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1990;19:569-75.
41. Lafferty WE, Glidden D, Hopkins SG. Survival trends of people with AIDS in Washington state. Am J Pub Health 1991;2:217-9.
42. Reichart PA, Langford-Kuntz A, Pohle HD. Epidemic oro-facial Kaposi's sarcoma (eKS)-report on 124 cases. Oral Oncol 1993;29B:187-9.
43. Epstein JB. Management of oral Kaposi's sarcoma and proposal for clinical staging. Oral Dis 1997;3:124-8.
44. Morris AK, Valley AW. Overview of the management of AIDS-related Kaposi's sarcoma. Ann Pharmacother 1996;30:1150-63.
45. Volberding PA. Therapy of Kaposi's sarcoma in AIDS. Semin Oncol 1984;11:60-7.
46. Anonymous. Kaposi's sarcoma and its management in AIDS patients. Recommendations from a Scandinavian study group. Scand J Infect Dis 1997;29:3-12.
47. Volberding PA. The role of chemotherapy for epidemic Kaposi's sarcoma. Semin Oncol 1987;14:23-6.
48. Lucatorto FM, Sapp JP. Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients. A preliminary study. Oral Surg Oral Med Oral Pathol 1993;75:192-8.
49. Muzyka BC, Glick M. Sclerotherapy for the treatment of nodular intraoral Kaposi's sarcoma in patients with AIDS. N Engl J Med 1993;328:210-1.
50. Epstein JB. Treatment of Oral Kaposi sarcoma with intralesional vinblastine. Cancer 1993;71:1722-5.
51. Pfrommer C, Tebbe B, Tidona CA, Wolfer U, Krengel S, Zeichardt H, et al. Progressive HHV-8-positive classic Kaposi's sarcoma: rapid response to interferon alpha-2a but persistence of HHV-8 DNA sequences in lesional skin. Br J Dermatol 1998;139:516-9.
52. Harris JW, Reed TA. Kaposi's sarcoma in AIDS: the role of radiation therapy. Front Rad Ther Oncol 1985;19:126-32.
53. Hill DR. The role of radiotherapy for epidemic Kaposi's sarcoma. Semin Oncol 1987;14:19-21.
54. Kao GD, Devine P, Mirza N. Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: acute response to radiation therapy. Arch Otolaryngol Head Neck Surg 1999;125:873-6.
55. Kirova YM, Belembaogo E, Frikha H, Haddad E, Calitchi E, Levy E, et al. Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases. Radiother Oncol 1998;46:19-22.
56. McGarvey ME, Tulpule A, Cai J, Aheng T, Masood R, Espina B, et al. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol 1998;10:413-21.
57. Goldman CK, Rogers BE, Douglas JT, Sosnowski BA, Ying W, Siegal GP, et al. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res 1997;57:1447-51.
58. Yarchoan R. Therapy for Kaposi's sarcoma: recent advances and experimental approaches. J Acquir Immune Defic Syndr 1999;21:s66-73.
59. Williams CD, Linch DC. Interferon alpha-2a. Br J Hosp Med 1997;57:436-9.
60. Miles S, Levine A, Feldstein M, Carden J, Cabriallas S, Marcus S, et al. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057. Cytokines Cell Mol Ther 1998;4:17-23.
61. Jie C, Tulpule A, Zheng T, Masood R, Espina B, Gill PS. Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol 1997;9:433-9.
62. Bower M, Fife K, Landau D, Gracie F, Phillips RH, Gazzard BG. Phase II trial of 13-cis-retinoic acid for poor risk HIV-associated Kaposi's sarcoma. Int J STD AIDS 1997;8:518-22.
63. Saiag P, Pavlovic M, Colerici T, Feauveau V, Nicolar JC, Emile D, et al. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA. AIDS 1998;12:2169-76.
64. Allison RR, Mang TS, Wilson BD. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin Cutan Med Surg 1998;17:153-63.
65. Curiel TJ, Piche A, Kasono K, Curiel DT. Gene therapy strategies for AIDS-related malignancies. Gene Ther 1997;4:1284-8.